Literature DB >> 1372334

Monoclonal antibody binding to peptide epitopes conjugated to synthetic branched chain polypeptide carriers. Influence of the carrier upon antibody recognition.

F Hudecz1, M R Price.   

Abstract

The peptide C A P D T R P A P G has been linked covalently to defined branched polypeptides with a polylysine backbone and side chains of DL-alanine or D-leucine-DL-alanine oligopeptides. The peptide was coupled via its N terminal cysteine to the side chains of the macromolecular carrier to ensure uniform orientation. The compounds were subjected to compositional analyses to characterise the degrees of substitution and secondary structural studies were performed using circular dichroism spectroscopy. The peptide selected for investigation contains the immunodominant sequence P D T R P A P which is expressed in the protein core of epithelial mucins. It is to this region that many anti-mucin monoclonal antibodies bind (Burchell et al., 1989; Price et al., 1990a,b). With these characterised constructs, it has been possible to evaluate the influence of secondary structure upon the binding of monoclonal antibodies which recognise short linear sequences in the synthetic antigenic peptide. The findings are relevant to the design and construction of synthetic immunogens and vaccines as well as to the production of synthetic analogues of clinically relevant antigens (in this case, epithelial mucins associated with breast and ovarian carcinomas).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372334     DOI: 10.1016/s0022-1759(12)80009-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Selection of peptide ligands for the antimucin core antibody C595 using phage display technology: definition of candidate epitopes for a cancer vaccine.

Authors:  P Laing; P Tighe; E Kwiatkowski; J Milligan; M Price; H Sewell
Journal:  Clin Mol Pathol       Date:  1995-06

2.  Production and characterization of a recombinant anti-MUC1 scFv reactive with human carcinomas.

Authors:  G Denton; M Sekowski; D I Spencer; O D Hughes; A Murray; H Denley; S J Tendler; M R Price
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Suppression of antibody responses to ricin A chain (RTA) by monoclonal anti-RTA antibodies.

Authors:  V S Byers; E B Austin; J A Clegg; G Denton; B Gunn; D Hooi; F Hudecz; M R Price; R W Baldwin
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.